Study population and study design
The study population (n = 32) was composed of competitive handball (n = 13) and football (n = 19) players from the first handball and football division in Germany. Handball and football players were considered separately due to their different physical constitution and the cardiovascular demands resulting from different types of exercise. All athletes provided informed consent after full explanation of the purpose and order of all procedures. The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethical committee of the University of Leipzig (073/18-ek).
All athletes were enrolled in the outpatient clinic of cardiology from May until July 2020 (handball players) and in July 2021 (football players). They were tested for SARS-CoV-2 and had a negative PCR test taken at most 48 hours before the examination. All athletes were asymptomatic and completely free of cardiovascular diseases or risk factors. A physical examination including vital parameters was performed in all subjects. Further, an electrocardiogram at rest, incremental CPET, and TTE (before and 5 minutes after CPET) were performed. Blood pressure measurements were performed brachial in suspine position at rest and 5 minutes after CPET at the time when TTE examination was started.
Incremental cardiopulmonary exercise test for handball players
CPET was performed on a semi-recumbent ergometer (GE eBike, GE Healthcare GmbH, Solingen, Germany) at a constant speed of 60–70 revolutions per minute (rpm). The test started at a workload of 50W with an increase of 50W every 3 minutes until volitional exhaustion occurred. Each subject continued for an additional 5-minute recovery period at a workload of 25W. In the CPET, ergospirometry data were collected using a digital spirometer (Vyntus™ CPX, Vyaire Germany, Hoechberg, Germany). Absolut and relative oxygen consumption (VO2max) were assessed to characterize the respiratory function of athletes. VO2max, minute ventilation (VE), and heart rate (HR) (GE Cardiosoft, GE Healthcare GmbH, Solingen, Germany) were monitored continuously at rest, during CPET, and during recovery. In addition to VO2max the individual fitness index for weight-independent comparisons of athletes’ cardiopulmonary exercise capacity was calculated by the following: absolute VO2max/(weight0,73)21.
Incremental cardiopulmonary exercise test for football players
Run performance diagnostics were done on a treadmill (HP Cosmos, Traunstein, Germany) to determine VO2max (Comsed, Rome, Italy), peak performance (Ppeak), maximum heart rate (HRmax), and lactate threshold (LT), as well as running economy and fractional utilization of VO2max at LT. The testing protocol contained a 2-phase test consisting of an incremental, sub-maximal exercise test (phase 1) followed by a ramp test (phase 2) interspersed with an 8 min break (4 min active walking at 4 km/h followed by 4 min passive rest)22.
Athletes started the incremental test at 8.0 km/h at a treadmill incline of 0%. The test was completed when i) blood lactate has increased by ≥ 1 mmol/L compared to the previous stage, ii) Borg value was > 17 (on the 6–20 scale), iii) the respiratory exchange ratio was > 1.0 in two consecutive stages. Criteria ii) and iii) were introduced to prevent athletes who do not achieve a blood lactate increase of ≥ 1 mmol/L from becoming prematurely exhausted before the upcoming ramp protocol. The last stage was terminated when the result of the blood lactate level of the previous stage was displayed and was ≥ 1 mmol/L compared with the penultimate stage (generally 1 to 1.5 minutes). The start speed of the ramp test and the speed of LT determined in the incremental test (equal to the speed of the stage before the lactate increase of ≥ 1 mmol/L) were increased by 1 km/h every minute until voluntary exhaustion.
Transthoracic echocardiography
TTE was performed using a Vivid E9 or E95 ultrasound system with a 4Vc phased array probe (GE Healthcare Vingmed Ultrasound AS, Horten, Norway). Post-processing analyses were performed with the EchoPac software (Version 203, GE Healthcare Vingmed Ultrasound AS, Horten, Norway). LV morphology was characterized by LV dimensions (M-Mode) including LV length, relative wall thickness (RWT), LV mass (LVM) (by the Devereux formula), and LV mass index (LVMi) according to current recommendations23. LV systolic function was characterized by LVEF based on LV end-diastolic (LVEDV) and end-systolic volume (LVESV) assessed by LV biplane planimetry by the modified Simpson’s rule in the apical 2- and 4-chamber view as well as by Cardiac Index (CI) (by Doppler echocardiography)24. Myocardial deformation was characterized by GLS using 2D speckle tracking analysis of the apical long axis-, 2-, and 4-chamber-view according to current recommendations3,25,26. The endocardial contour was manually adjusted, whereas only segments with accurate tracking were accepted. Tracking areas were manually adjusted to enable full myocardial tracking.
Additionally, GWI was calculated by using the longitudinal strain analysis of the apical LV long axis-, 2-, and 4-chamber-view coupled with the noninvasive blood pressure measurements to attain a pressure-strain loop of the LV27. In all athletes, the change in GLS (ΔGLS) and GWI (ΔGWI) was calculated before compared with after CPET.
Diastolic function was characterized by maximum blood flow velocities (Vmax) of E- and A-wave, E/A-ratio, myocardial Vmax of e’ and a’ of the basal septal and lateral mitral annulus, septal and lateral E/e´-ratio (including average E’/e’-ratio (septal and lateral)) and systolic pulmonary artery pressure (sPAP) according to current recommendations28.
Statistical analysis
All statistical analyses were performed using SPSS Statistics (version 24.0, IBM, Armonk, NY) and Microsoft Office Excel (version 16.53, Microsoft). Continuous variables were expressed as mean value ± standard deviation (SD). Further, percentage changes after CPET compared to resting conditions were stated. In consideration of the small sample size, we decided to forgo distribution analyses. Statistical significance was accepted for P value < 0.05. The student’s t-test was used to compare the echocardiographic results before and after CPET. Comparisons between more than two groups (subgroup analyses) were performed by one-way Analysis of Variance (ANOVA). Pearson correlation coefficient r was used to test the correlation between different echocardiographic parameters at rest, after CPET and for the percentage change of each parameter after CPET compared to resting conditions: r ≤ 0.5 (poor correlation), r = 0.5–0.7 (moderate correlation) and r ≥ 0.7 (good correlation).
Intra- and interobserver variabilities of main echocardiographic parameters (LV volumes, LVEF, GLS, CI, sPAP) were assessed in randomly selected athletes (n = 10). The second investigator used the same datasets, and both were blinded to each other’s results.